Serum Prostate-specific Antigen to Predict the Presence of Bladder Outlet Obstruction in Men with Urinary Symptoms
Affiliations
Objective: To determine whether prostate specific antigen (PSA) level can usefully predict or exclude bladder outlet obstruction (BOO), in men with lower urinary tract symptoms (LUTS).
Patients And Methods: A cohort of men from 1996 to 1999 who had LUTS caused by BPH was evaluated by serum PSA and pressure-flow urodynamic studies, and a blinded comparison made. The settings were teaching hospitals in London, UK and L'Aquila, Italy. Men (302) were referred by primary-care practitioners with LUTS and a PSA of < 10 ng/mL. Regression analysis was used to predict the extent of BOO, and create likelihood ratios and predictive values for BOO according to the PSA value.
Results: PSA was significantly associated with BOO (P < 0.001; r2 0.07), with significant likelihood ratios altering the probability of BOO. If the PSA was > 4 ng/mL, mild or definite BOO was likely (89%), whereas if the PSA was <2 ng/mL, there was about a one-third chance each of no, mild and definite BOO.
Conclusion: High PSA levels in patients with LUTS are significantly associated with BOO; low PSA levels mean that definite BOO is unlikely.
Raffo M, Capogrosso P, Pozzi E, Belladelli F, Corsini C, Bertini A Int Urol Nephrol. 2025; .
PMID: 40045050 DOI: 10.1007/s11255-025-04432-2.
Edwards A, Agarwal R, Bates J, Bray A, Milosevic S, Thomas-Jones E Health Technol Assess. 2025; 29(1):1-140.
PMID: 39895567 PMC: 11874884. DOI: 10.3310/RGTW5711.
Cahill T, Withey S, Hazell S, Cahill D, Kinsella N BJUI Compass. 2025; 6(1):e478.
PMID: 39877561 PMC: 11771501. DOI: 10.1002/bco2.478.
From BPH to male LUTS: a 20-year journey of the EAU guidelines.
Gravas S, Malde S, Cornu J, Gacci M, Gratzke C, Herrmann T Prostate Cancer Prostatic Dis. 2023; 27(1):48-53.
PMID: 37488274 DOI: 10.1038/s41391-023-00700-3.
Lee Y, Lee J, Kim J, Lee H, Oh J, Lee S Asian J Androl. 2019; 21(5):486-492.
PMID: 30829291 PMC: 6732887. DOI: 10.4103/aja.aja_127_18.